These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34152238)

  • 1. Effectiveness of mHealth management with an implantable glucose sensor and a mobile application among Chinese adults with type 2 diabetes.
    Guo M; Meng F; Guo Q; Bai T; Hong Y; Song F; Ma Y
    J Telemed Telecare; 2023 Sep; 29(8):632-640. PubMed ID: 34152238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
    Agarwal P; Mukerji G; Desveaux L; Ivers NM; Bhattacharyya O; Hensel JM; Shaw J; Bouck Z; Jamieson T; Onabajo N; Cooper M; Marani H; Jeffs L; Bhatia RS
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10321. PubMed ID: 30632972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile Phone-Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
    Sun C; Sun L; Xi S; Zhang H; Wang H; Feng Y; Deng Y; Wang H; Xiao X; Wang G; Gao Y; Wang G
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10664. PubMed ID: 30609983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mobile-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes: Retrospective, Propensity Score-Matched Cohort Study.
    Li J; Sun L; Wang Y; Guo L; Li D; Liu C; Sun N; Xu Z; Li S; Jiang Y; Wang Y; Zhang S; Chen L
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e15390. PubMed ID: 32159518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Mobile Phone-Based Glucose-Monitoring and Feedback System for Type 2 Diabetes Management in Multiple Primary Care Clinic Settings: Cluster Randomized Controlled Trial.
    Yang Y; Lee EY; Kim HS; Lee SH; Yoon KH; Cho JH
    JMIR Mhealth Uhealth; 2020 Feb; 8(2):e16266. PubMed ID: 32130172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial.
    Lee EY; Cha SA; Yun JS; Lim SY; Lee JH; Ahn YB; Yoon KH; Hyun MK; Ko SH
    J Med Internet Res; 2022 Jul; 24(7):e37430. PubMed ID: 35900817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Gerber BS; Biggers A; Tilton JJ; Smith Marsh DE; Lane R; Mihailescu D; Lee J; Sharp LK
    JAMA Netw Open; 2023 Sep; 6(9):e2333629. PubMed ID: 37773498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data.
    Krishnakumar A; Verma R; Chawla R; Sosale A; Saboo B; Joshi S; Shaikh M; Shah A; Kolwankar S; Mattoo V
    J Med Internet Res; 2021 Mar; 23(3):e17908. PubMed ID: 33764306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review.
    Eberle C; Löhnert M; Stichling S
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e23477. PubMed ID: 33587045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of a Traditional Chinese Medicine-Based Mobile Health App for Individuals With Prediabetes: Randomized Controlled Trial.
    Chung HW; Tai CJ; Chang P; Su WL; Chien LY
    JMIR Mhealth Uhealth; 2023 Jun; 11():e41099. PubMed ID: 37338977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial.
    Wayne N; Perez DF; Kaplan DM; Ritvo P
    J Med Internet Res; 2015 Oct; 17(10):e224. PubMed ID: 26441467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study.
    Yin W; Liu Y; Hu H; Sun J; Liu Y; Wang Z
    PLoS One; 2022; 17(9):e0275251. PubMed ID: 36174028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Intervention by a Patient-Designed Do-It-Yourself Mobile Device App Reduces HbA1c in Children and Adolescents with Type 1 Diabetes: A Randomized Double-Crossover Study.
    Klee P; Bussien C; Castellsague M; Combescure C; Dirlewanger M; Girardin C; Mando JL; Perrenoud L; Salomon C; Schneider F; Schwitzgebel VM
    Diabetes Technol Ther; 2018 Dec; 20(12):797-805. PubMed ID: 30403495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mobile health applications on self-management in patients with type 2 diabetes mellitus: protocol of a systematic review.
    Bene BA; O'Connor S; Mastellos N; Majeed A; Fadahunsi KP; O'Donoghue J
    BMJ Open; 2019 Jun; 9(6):e025714. PubMed ID: 31243029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol for the road to hierarchical diabetes management at primary care (ROADMAP) study in China: a cluster randomised controlled trial.
    Jia W; Zhang P; Duolikun N; Zhu D; Li H; Bao Y; Li X; Liu Y;
    BMJ Open; 2020 Jan; 10(1):e032734. PubMed ID: 31911516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an Integrative Mobile Health Intervention in Patients With Hypertension and Diabetes: Crossover Study.
    Oh SW; Kim KK; Kim SS; Park SK; Park S
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e27192. PubMed ID: 35014961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study.
    Koot D; Goh PSC; Lim RSM; Tian Y; Yau TY; Tan NC; Finkelstein EA
    JMIR Mhealth Uhealth; 2019 May; 7(5):e12965. PubMed ID: 31127720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Personalized Mobile Health Program for Type 2 Diabetes During the COVID-19 Pandemic: Single-Group Pre-Post Study.
    Ang IYH; Tan KXQ; Tan C; Tan CH; Kwek JWM; Tay J; Toh SA
    JMIR Diabetes; 2021 Jul; 6(3):e25820. PubMed ID: 34111018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial.
    Toro-Ramos T; Michaelides A; Anton M; Karim Z; Kang-Oh L; Argyrou C; Loukaidou E; Charitou MM; Sze W; Miller JD
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17842. PubMed ID: 32459631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.